Various tools are required for the management of diabetes therapy. On the one hand, it is necessary to determine the glucose level in the blood or tissue. On the other hand, there is now a wide range of aids for the application of insulin. In addition to these aids, insulin is also an indispensable part of therapy, especially for people with type 1 diabetes mellitus. However, the increasing connectivity of technical aids can also increase the susceptibility of these systems to errors – even though the outcome of the therapy has been proven to improve.
Autoren
- Theresia Schoppe
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Evidence, pathophysiology and management in the light of current data
Heart failure with improved ejection fraction (HFimpEF)
- Early rheumatoid arthritis
C1M has potential as a biomarker
- Osteoporosis
Risk-stratified therapy with osteoanabolic agents improves outcomes
- "Swiss Health Care Atlas"
New indicator: medication for weight regulation
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Longevity Medicine 2025
From anti-ageing to precision prevention
- Treatment of pancreatitis: current study data
How can the risk-benefit profile be improved?
- Prurigo and PN